The Impact Of COVID-19 On Clinical Trials
Clinical trials for therapeutic areas aside from COVID-19 are experiencing disruptions and delays as social distancing measures and travel restrictions are implemented across the world.
You may also be interested in...
Agency cites “unexpected and large drop in collections” in slashing user-fee-setting contract.
Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.
More patient-centric trial designs also may be coming due to pandemic-related advances, Marks says.